Compare CB & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CB | CI |
|---|---|---|
| Founded | 1985 | 1792 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.9B | 79.0B |
| IPO Year | 1995 | 2018 |
| Metric | CB | CI |
|---|---|---|
| Price | $325.28 | $282.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | $332.76 | ★ $349.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | 1.19% | ★ 2.13% |
| EPS Growth | 13.13 | ★ 83.00 |
| EPS | 5.88 | ★ 6.26 |
| Revenue | $59,402,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | N/A | $5.91 |
| Revenue Next Year | $5.31 | $5.92 |
| P/E Ratio | $55.74 | ★ $45.48 |
| Revenue Growth | 6.54 | ★ 11.24 |
| 52 Week Low | $264.10 | $239.51 |
| 52 Week High | $345.67 | $338.89 |
| Indicator | CB | CI |
|---|---|---|
| Relative Strength Index (RSI) | 50.99 | 46.66 |
| Support Level | $317.41 | $280.76 |
| Resistance Level | $334.77 | $293.09 |
| Average True Range (ATR) | 6.20 | 5.84 |
| MACD | 0.87 | -0.22 |
| Stochastic Oscillator | 65.00 | 44.32 |
ACE acquired Chubb in 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in over 50 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.